This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Nationally Recognized Pharmacy Brokerage Company Aventine Group Successfully Arranges Acquisition Of Private Community Pharmacy By Rite Aid

NEW YORK, Feb. 13, 2013 /PRNewswire/ -- Aventine Group, a nationally recognized pharmacy brokerage and consulting firm, has announced the sale of a private community pharmacy to Rite Aid, the national U.S. retail pharmacy chain. Brokered for an undisclosed amount, the transaction further solidifies Aventine's position as a leader in the pharmacy merger and acquisition market. This five times multiple dollar transaction was achieved by their expert team of consultants who came together and executed key sales initiatives by focusing on the customer experience.

Elan Katz, CEO of Aventine Group, credits the success of this undertaking to the exceptional knowledge and insights possessed by his team of professionals. "As a registered pharmacist myself, I'm extremely familiar with what it takes to run a successful pharmacy," he says. "Our unique insights have proven to be beneficial and have allowed Aventine Group to be successful."

In brokering the deal, Aventine's consultants combined a stellar execution of strategic sales tactics with a focus on the customer to guarantee the success of this transaction. When it came to the calculation of an accurate selling price for the pharmacy, their decades of experience in the field of retail pharmacy served them well. Katz is proud of the fact that his experts understand the difficulties faced by the owners of pharmacies when attempting to sell their property.

In arriving at a fair selling price, Aventine's experts combined such crucial financial indicators as reports of past and current performance with a careful consideration of comparable sales of similar businesses.

While proper appraisal of the private pharmacy's value was critical, it was only part of the picture. Aventine also confirmed that the pharmacy's owners possessed all state-required documents that would be required to see the transaction through to a successful and lawful conclusion. This entailed the aggregation and collation of their profit and loss statements, federal income tax returns, assets and loans along with lease-related documents, names of outside advisors and a copy of their franchise agreement.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,719.92 -78.57 -0.44%
S&P 500 2,080.41 -9.70 -0.46%
NASDAQ 5,108.6660 -18.8590 -0.37%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs